24.50
Ideaya Biosciences Inc (IDYA) 最新ニュース
TD Cowen Bullish on Ideaya’s (IDYA) Oncology Pipeline - MSN
IDEAYA Biosciences (NASDAQ:IDYA) Research Coverage Started at TD Cowen - Defense World
What analysts say about IDEAYA Biosciences Inc. stockUnstoppable investment returns - Autocar Professional
What makes IDEAYA Biosciences Inc. stock price move sharplyFree Investing Community - Newser
IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma - The Malaysian Reserve
What drives IDEAYA Biosciences Inc. stock pricePhenomenal investment performance - PrintWeekIndia
IDEAYA to present phase 2 data on uveal melanoma drug at ESMO By Investing.com - Investing.com South Africa
IDEAYA to present phase 2 data on uveal melanoma drug at ESMO - Investing.com India
IDEAYA Biosciences Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth Strategy - Nasdaq
IDEAYA Biosciences: Precision Oncology Pipeline and Synthetic Lethality Catalysts - AInvest
IDEAYA's First-in-Class Cancer Pipeline: Major Clinical Updates Coming at 10th Anniversary R&D Day - Stock Titan
Signaturefd LLC Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC - The Malaysian Reserve
IDEAYA Biosciences Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com
Is IDEAYA Biosciences Inc. a good long term investmentRobust financial gains - jammulinksnews.com
Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025 - TipRanks
Breakthrough Lung Cancer Drug IDE849 Shows First Human Results: 70+ Patient Data Coming at WCLC 2025 - Stock Titan
Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
IDEAYA Biosciences: TD Cowen initiates coverage with Buy rating. - AInvest
Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences - TipRanks
TD Cowen initiates Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com Canada
IDEAYA Biosciences CEO Fireside Chat: Precision Medicine Updates at BTIG Conference - Stock Titan
Teacher Retirement System of Texas Cuts Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
(IDYA) Proactive Strategies - news.stocktradersdaily.com
Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser
大文字化:
|
ボリューム (24 時間):